HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georg Kemmler Selected Research

Cognitive Dysfunction

1/2018Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease.
9/2015The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment.
2/2014Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.
3/2011Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease.
1/2011Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects.
1/2008Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
10/2007Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.
3/2003Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
6/2002Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georg Kemmler Research Topics

Disease

34Schizophrenia (Dementia Praecox)
02/2020 - 01/2002
13Alzheimer Disease (Alzheimer's Disease)
01/2021 - 03/2003
10Neoplasms (Cancer)
05/2022 - 03/2003
9Cognitive Dysfunction
01/2018 - 06/2002
6Breast Neoplasms (Breast Cancer)
10/2016 - 01/2004
5Body Weight (Weight, Body)
06/2007 - 12/2003
4Mood Disorders (Mood Disorder)
01/2022 - 01/2009
4Alcoholism (Alcohol Abuse)
01/2021 - 03/2006
4Atrophy
09/2008 - 03/2003
3Bipolar Disorder (Manic Depressive Psychosis)
01/2020 - 01/2016
3Weight Gain
05/2014 - 10/2006
3Mental Disorders (Mental Disorder)
09/2013 - 03/2003
3Insulin Resistance
06/2007 - 12/2003
3Dementia (Dementias)
01/2006 - 03/2003
2Psychotic Disorders (Schizoaffective Disorder)
01/2020 - 12/2005
2Weight Loss (Weight Reduction)
05/2014 - 09/2013
2Disease Progression
02/2014 - 10/2007
2Malnutrition (Nutritional Deficiencies)
01/2014 - 02/2009
2Treatment-Resistant Schizophrenia
12/2011 - 09/2003
2Substance-Related Disorders (Drug Abuse)
04/2011 - 12/2008
2Wounds and Injuries (Trauma)
12/2005 - 10/2004
2Fatigue
05/2005 - 03/2003
1Treatment-Resistant Depressive Disorder
01/2022
1Seizures (Absence Seizure)
01/2022
1Feeding and Eating Disorders (Eating Disorder)
03/2019
1Vomiting
03/2019
1Gambling (Pathological Gambling)
01/2016
1Psychomotor Agitation (Akathisia)
06/2015
1Movement Disorders (Movement Disorder)
06/2015
1Dysarthria (Spastic Dysarthria)
09/2014
1Dyskinesias (Dyskinesia)
09/2014
1Torticollis (Wryneck)
09/2014
1Dystonia (Limb Dystonia)
09/2014
1Obesity
08/2014
1End Stage Liver Disease
01/2014
1Renal Insufficiency (Renal Failure)
01/2014
1Iron Deficiencies
01/2014
1Morbid Obesity
09/2013
1Taste Disorders (Taste Disorder)
12/2012
1Menstruation Disturbances
06/2011
1Ejaculatory Dysfunction
06/2011
1Galactorrhea
06/2011

Drug/Important Bio-Agent (IBA)

27Antipsychotic Agents (Antipsychotics)IBA
02/2020 - 01/2002
6Pharmaceutical PreparationsIBA
02/2020 - 08/2005
6Clozapine (Clozaril)FDA LinkGeneric
12/2011 - 09/2003
6Olanzapine (Zyprexa)FDA Link
11/2006 - 12/2003
5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2006
4Amisulpride (Solian)IBA
06/2011 - 12/2005
3LipidsIBA
09/2015 - 03/2006
3ziprasidone (Geodon)FDA Link
06/2015 - 12/2005
3ProlactinIBA
06/2011 - 01/2005
3Amyloid beta-PeptidesIBA
09/2008 - 08/2005
3Pemetrexed (MTA)FDA Link
09/2008 - 08/2005
3Insulin (Novolin)FDA Link
09/2008 - 08/2005
2Phosphatidylcholines (Phosphatidylcholine)IBA
01/2021 - 09/2015
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 - 01/2014
2Valproic Acid (Depakote)FDA LinkGeneric
01/2020 - 03/2006
2N 30IBA
01/2016 - 07/2004
2Anastrozole (Arimidex)FDA LinkGeneric
08/2014 - 10/2012
2Proteins (Proteins, Gene)FDA Link
02/2014 - 03/2011
2ApolipoproteinsIBA
11/2010 - 10/2007
2Ethanol (Ethyl Alcohol)IBA
02/2009 - 01/2005
2Quetiapine Fumarate (Seroquel)FDA Link
03/2006 - 12/2005
2Risperidone (Risperdal Consta)FDA LinkGeneric
12/2005 - 08/2005
1phytobacteriomycin (PBM)IBA
05/2022
1Adenosine Diphosphate (ADP)IBA
01/2021
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2021
1LithiumIBA
01/2020
1DiureticsIBA
03/2019
1Testosterone (Sustanon)FDA Link
03/2019
1Bile Acids and Salts (Bile Acids)IBA
01/2018
1Lithocholic AcidIBA
01/2018
1AntioxidantsIBA
01/2016
1DDTIBA
01/2016
1BilirubinIBA
01/2016
1Biological ProductsIBA
01/2016
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
09/2015
1Haloperidol (Haldol)FDA LinkGeneric
06/2015
1Botulinum Toxins (Botulinum Toxin)IBA
09/2014
1salicylhydroxamic acid (SHAM)IBA
09/2014
1sibutramine (Meridia)FDA Link
05/2014
1pro-brain natriuretic peptide (1-76)IBA
02/2014
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2014
1IronIBA
01/2014
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
09/2013
1Oxytocin (Pitocin)FDA LinkGeneric
11/2012
1Epirubicin (Ellence)FDA LinkGeneric
04/2012
1GemcitabineFDA Link
04/2012
1Capecitabine (Xeloda)FDA Link
04/2012
1Docetaxel (Taxotere)FDA Link
04/2012

Therapy/Procedure

10Therapeutics
06/2019 - 03/2003
7Drug Therapy (Chemotherapy)
10/2016 - 05/2003
2Aftercare (After-Treatment)
07/2011 - 06/2002
1General Anesthesia
01/2022
1Anesthesia
01/2022
1Emergency Treatment
01/2018
1Injections
09/2014
1Liver Transplantation
01/2014
1Bariatric Surgery
09/2013
1Palliative Care (Palliative Therapy)
08/2011